Advertisement
Review Article| Volume 102, ISSUE 5, P715-737, October 2022

Abdominal Tumors

Wilms, Neuroblastoma, Rhabdomyosarcoma, and Hepatoblastoma
Published:September 07, 2022DOI:https://doi.org/10.1016/j.suc.2022.07.006

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Surgical Clinics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Erdmann F.
        • Frederiksen L.E.
        • Bonaventure A.
        • et al.
        Childhood cancer: Survival, treatment modalities, late effects and improvements over time.
        Cancer Epidemiol. 2021; 71https://doi.org/10.1016/J.CANEP.2020.101733
        • Landier W.
        • Skinner R.
        • Wallace W.H.
        • et al.
        Surveillance for Late Effects in Childhood Cancer Survivors.
        J Clin Oncol. 2018; 36: 2216-2222
        • Hawkins M.M.
        • Lancashire E.R.
        • Winter D.L.
        • et al.
        The British Childhood Cancer Survivor Study: Objectives, methods, population structure, response rates and initial descriptive information.
        Pediatr Blood Cancer. 2008; 50: 1018-1025
        • Ward E.
        • DeSantis C.
        • Robbins A.
        • et al.
        Childhood and adolescent cancer statistics.
        CA Cancer J Clin. 2014; 64: 83-103
        • PDQ Pediatric Treatment Editorial Board
        Wilms Tumor and Other Childhood Kidney Tumors Treatment (PDQ®): Health Professional Version. PDQ Cancer Information Summaries.
        (Available at:) (Accessed April 10, 2022)
        • Callaghan M.U.
        • Wong T.E.
        • Federici A.B.
        Treatment of acquired von Willebrand syndrome in childhood.
        Blood. 2013; 122: 2019-2022
        • Scott J.P.
        • Montgomery R.R.
        • Tubergen D.G.
        • et al.
        Acquired von Willebrand’s disease in association with Wilm’s tumor: regression following treatment.
        Blood. 1981; 58: 665-669
        • Ehrlich P.F.
        • Chi Y.Y.
        • Chintagumpala M.M.
        • et al.
        Results of Treatment for Patients With Multicentric or Bilaterally Predisposed Unilateral Wilms Tumor (AREN0534): A report from the Children’s Oncology Group.
        Cancer. 2020; 126: 3516-3525
        • Zhang Y.
        • Song H.C.
        • Fang Y.Y.
        • et al.
        Preoperative Wilms tumor rupture in children.
        Int Urol Nephrol. 2021; 53: 619-625
        • Khanna G.
        • Rosen N.
        • Anderson J.R.
        • et al.
        Evaluation of diagnostic performance of CT for detection of tumor thrombus in children with Wilms tumor: a report from the Children’s Oncology Group.
        Pediatr Blood Cancer. 2012; 58: 551-555
        • Qureshi S.S.
        • Bhagat M.
        • Smriti V.
        • et al.
        Intravascular extension of Wilms tumor: Characteristics of tumor thrombus and their impact on outcomes.
        J Pediatr Urol. 2021; 17: 69.e1-69.e8
        • Agarwal S.
        • Mullikin D.
        • Scheurer M.E.
        • et al.
        Role of anticoagulation in the management of tumor thrombus: A 10-year single-center experience.
        Pediatr Blood Cancer. 2021; 68https://doi.org/10.1002/PBC.29173
        • Aldrink J.H.
        • Heaton T.E.
        • Dasgupta R.
        • et al.
        Update on Wilms tumor.
        J Pediatr Surg. 2019; 54: 390-397
        • Kist-Van Holthe J.E.
        • Ho P.L.
        • Stablein D.
        • et al.
        Outcome of renal transplantation for Wilms’ tumor and Denys-Drash syndrome: a report of the North American Pediatric Renal Transplant Cooperative Study.
        Pediatr Transpl. 2005; 9: 305-310
        • Bhatnagar S.
        Management of Wilms’ tumor: NWTS vs SIOP.
        J Indian Assoc Pediatr Surg. 2009; 14: 6-14
        • Treger T.D.
        • Chowdhury T.
        • Pritchard-Jones K.
        • et al.
        The genetic changes of Wilms tumour.
        Nat Rev Nephrol. 2019; 15: 240-251
        • Stokes C.L.
        • Stokes W.A.
        • Kalapurakal J.A.
        • et al.
        Timing of radiation therapy in pediatric wilms tumor: a report from the national cancer database.
        Int J Radiat Oncol Biol Phys. 2018; 101: 453-461
        • Pater L.
        • Melchior P.
        • Rübe C.
        • et al.
        Wilms tumor.
        Pediatr Blood Cancer. 2021; 68: e28257
        • Malogolowkin M.H.
        • Spreafico F.
        • Dome J.S.
        • et al.
        Incidence and outcomes of patients with late recurrence of Wilms’ tumor.
        Pediatr Blood Cancer. 2013; 60: 1612-1615
        • Scott R.H.
        • Walker L.
        • Olsen E.
        • et al.
        Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice.
        Arch Dis Child. 2006; 91: 995-999
        • Breslow N.E.
        • Collins A.J.
        • Ritchey M.L.
        • et al.
        End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System.
        J Urol. 2005; 174: 1972-1975
        • Yan P.
        • Qi F.
        • Bian L.
        • et al.
        Comparison of incidence and outcomes of neuroblastoma in children, adolescents, and adults in the United States: a surveillance, epidemiology, and end results (SEER) Program Population Study.
        Med Sci Monit. 2020; 26https://doi.org/10.12659/MSM.927218
        • Mossé Y.P.
        • Deyell R.J.
        • Berthold F.
        • et al.
        Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project.
        Pediatr Blood Cancer. 2014; 61: 627-635
        • Katzenstein H.M.
        • Kent P.M.
        • London W.B.
        • et al.
        Treatment and outcome of 83 children with intraspinal neuroblastoma: the Pediatric Oncology Group experience.
        J Clin Oncol. 2001; 19: 1047-1055
        • Weintraub M.
        • Waldman E.
        • Koplewitz B.
        • et al.
        A sequential treatment algorithm for infants with stage 4s neuroblastoma and massive hepatomegaly.
        Pediatr Blood Cancer. 2012; 59: 182-184
        • Irwin M.S.
        • Naranjo A.
        • Zhang F.F.
        • et al.
        Revised Neuroblastoma Risk Classification System: A Report From the Children’s Oncology Group.
        J Clin Oncol. 2021; 39: 3229-3241
        • Nuchtern J.G.
        • London W.B.
        • Barnewolt C.E.
        • et al.
        A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children’s Oncology Group study.
        Ann Surg. 2012; 256: 573-580
        • PDQ Screening and Prevention Editorial Board
        Neuroblastoma Screening (PDQ®): Health Professional Version. PDQ Cancer Information Summaries.
        (Available at:) (Accessed April 10, 2022)
        • Perez C.A.
        • Matthay K.K.
        • Atkinson J.B.
        • et al.
        Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children’s cancer group study.
        J Clin Oncol. 2000; 18: 18-26
        • Whittle S.B.
        • Smith V.
        • Doherty E.
        • et al.
        Overview and recent advances in the treatment of neuroblastoma.
        Expert Rev Anticancer Ther. 2017; 17: 369-386
        • Gains J.E.
        • Moroz V.
        • Aldridge M.D.
        • et al.
        A phase IIa trial of molecular radiotherapy with 177-lutetium DOTATATE in children with primary refractory or relapsed high-risk neuroblastoma.
        Eur J Nucl Med Mol Imaging. 2020; 47: 2348-2357
        • Atherine K.
        • Atthay K.M.
        • Udith J.
        • et al.
        Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children’s Cancer Group.
        N Engl J Med. 1999; 341: 1165-1173
        • London W.B.
        • Bagatell R.
        • Weigel B.J.
        • et al.
        Historical time to disease progression and progression-free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children’s Oncology Group early-phase trials.
        Cancer. 2017; 123: 4914-4923
        • Laverdiére C.
        • Liu Q.
        • Yasui Y.
        • et al.
        Long-term outcomes in survivors of neuroblastoma: a report from the Childhood Cancer Survivor Study.
        J Natl Cancer Inst. 2009; 101: 1131-1140
        • Lee K.L.
        • Ma J.F.
        • Shortliffe L.D.
        Neuroblastoma: management, recurrence, and follow-up.
        Urol Clin North Am. 2003; 30: 881-890
        • Beverly Raney R.
        • Anderson J.R.
        • Barr F.G.
        • et al.
        Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.
        J Pediatr Hematol Oncol. 2001; 23: 215-220
        • Rhee D.S.
        • Rodeberg D.A.
        • Baertschiger R.M.
        • et al.
        Update on pediatric rhabdomyosarcoma: A report from the APSA Cancer Committee.
        J Pediatr Surg. 2020; 55: 1987-1995
        • PDQ Pediatric Treatment Editorial Board
        Childhood Rhabdomyosarcoma Treatment (PDQ®): Health Professional Version. PDQ Cancer Information Summaries.
        (Available at:) (Accessed April 10, 2022)
        • Lawrence W.
        • Hays D.M.
        • Heyn R.
        • et al.
        Surgical lessons from the Intergroup Rhabdomyosarcoma Study (IRS) pertaining to extremity tumors.
        World J Surg. 1988; 12: 676-684
        • Cecchetto G.
        • Guglielmi M.
        • Inserra A.
        • et al.
        Primary re-excision: The Italian experience in patients with localized soft-tissue sarcomas.
        Pediatr Surg Int. 2001; 17: 532-534
        • Lautz T.B.
        • Chi Y.Y.
        • Li M.
        • et al.
        Benefit of delayed primary excision in rhabdomyosarcoma: A report from the Children’s Oncology Group.
        Cancer. 2021; 127: 275-283
        • Lobeck I.
        • Dupree P.
        • Karns R.
        • et al.
        Quality assessment of lymph node sampling in rhabdomyosarcoma: A surveillance, epidemiology, and end results (SEER) program study.
        J Pediatr Surg. 2017; 52: 614-617
        • Routh J.C.
        • Dasgupta R.
        • Chi Y.Y.
        • et al.
        Impact of local control and surgical lymph node evaluation in localized paratesticular rhabdomyosarcoma: A report from the Children’s Oncology Group Soft-tissue Sarcoma Committee.
        Int J Cancer. 2020; 147: 3168-3176
        • Bradley J.A.
        • Kayton M.L.
        • Chi Y.Y.
        • et al.
        Treatment Approach and Outcomes in Infants With Localized Rhabdomyosarcoma: A Report From the Soft-tissue Sarcoma Committee of the Children’s Oncology Group.
        Int J Radiat Oncol Biol Phys. 2019; 103: 19-27
        • Million L.
        • Anderson J.
        • Breneman J.
        • et al.
        Influence of noncompliance with radiation therapy protocol guidelines and operative bed recurrences for children with rhabdomyosarcoma and microscopic residual disease: a report from the Children’s Oncology Group.
        Int J Radiat Oncol Biol Phys. 2011; 80: 333-338
        • Siegel R.L.
        • Miller K.D.
        • Fuchs H.E.
        • et al.
        Cancer Statistics, 2021.
        CA Cancer J Clin. 2021; 71: 7-33
        • Shern J.F.
        • Selfe J.
        • Izquierdo E.
        • et al.
        Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.
        J Clin Oncol. 2021; 39: 2859-2871
        • Vaarwerk B.
        • Mallebranche C.
        • Affinita M.C.
        • et al.
        Is surveillance imaging in pediatric patients treated for localized rhabdomyosarcoma useful? The European experience.
        Cancer. 2020; 126: 823-831
        • Li H.
        • Sisoudiya S.D.
        • Martin-Giacalone B.A.
        • et al.
        Germline Cancer Predisposition Variants in Pediatric Rhabdomyosarcoma: A Report From the Children’s Oncology Group.
        J Natl Cancer Inst. 2021; 113: 875-883
        • Daniel C.L.
        • Kohler C.L.
        • Stratton K.L.
        • et al.
        Predictors of colorectal cancer surveillance among radiation-treated survivors of childhood cancer: a report from the childhood cancer survivor study.
        Cancer. 2015; 121: 1856
        • Heyn R.
        • Beverly Roney R.
        • Hays D.M.
        • et al.
        Late effects of therapy in patients with paratesticular rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee.
        J Clin Oncol. 1992; 10: 614-623
        • Piver M.S.
        • Rose P.G.
        Long-term follow-up and complications of infants with vulvovaginal embryonal rhabdomyosarcoma treated with surgery, radiation therapy, and chemotherapy.
        Obstet Gynecol. 1988; 71 (Available at:) (Accessed April 10, 2022): 435-437
        • Youn P.
        • Milano M.T.
        • Constine L.S.
        • et al.
        Long-term cause-specific mortality in survivors of adolescent and young adult bone and soft-tissue sarcoma: A population-based study of 28,844 patients.
        Cancer. 2014; 120: 2334-2342
        • Vaarwerk B.
        • Hol M.L.F.
        • Schoot R.A.
        • et al.
        AMORE treatment as salvage treatment in children and young adults with relapsed head-neck rhabdomyosarcoma.
        Radiother Oncol. 2019; 131: 21-26
        • Mattos VDA de
        • Ferman S.
        • Magalhães D.M.A.
        • et al.
        Dental and craniofacial alterations in long-term survivors of childhood head and neck rhabdomyosarcoma.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2019; 127: 272-281
        • Schoot R.A.
        • Hol M.L.F.
        • Merks J.H.M.
        • et al.
        Facial asymmetry in head and neck rhabdomyosarcoma survivors.
        Pediatr Blood Cancer. 2017; 64https://doi.org/10.1002/PBC.26508
        • Darbari A.
        • Sabin K.M.
        • Shapiro C.N.
        • et al.
        Epidemiology of primary hepatic malignancies in U.S. children.
        Hepatology. 2003; 38: 560-566
        • Kremer N.
        • Walther A.E.
        • Tiao G.M.
        Management of hepatoblastoma: an update.
        Curr Opin Pediatr. 2014; 26: 362-369
        • Towbin A.J.
        • Meyers R.L.
        • Woodley H.
        • et al.
        2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT).
        Pediatr Radiol. 2018; 48: 536-554
        • Huang Y.L.
        • Shih S.L.
        • Liu H.C.
        • et al.
        Hepatoblastoma with tumor extension through the inferior vena cava into the right atrium.
        J Pediatr Gastroenterol Nutr. 2010; 50: 577
        • Shimizu S.
        • Sakamoto S.
        • Fukuda A.
        • et al.
        The extracorporeal circulation with transdiaphragmatic approach in living-donor liver transplantation for HB with atrial extension of tumor thrombus: A case report.
        Pediatr Transpl. 2021; 25https://doi.org/10.1111/PETR.13948
        • Meyers R.
        • Hiyama E.
        • Czauderna P.
        • et al.
        Liver tumors in pediatric patients.
        Surg Oncol Clin N Am. 2021; 30: 253-274
        • PDQ Pediatric Treatment Editorial Board
        Childhood Adrenocortical Carcinoma Treatment (PDQ®): Health Professional Version. PDQ Cancer Information Summaries.
        (Available at:) (Accessed April 10, 2022)
        • Caicedo L.A.
        • Sabogal A.
        • Serrano O.
        • et al.
        Hepatoblastoma: transplant versus resection experience in a latin american transplant center.
        Transpl Direct. 2017; 3: e165
        • Kueht M.
        • Thompson P.
        • Rana A.
        • et al.
        Effects of an early referral system on liver transplantation for hepatoblastoma at Texas Children’s Hospital.
        Pediatr Transpl. 2016; 20: 515-522
        • Yang T.
        • Whitlock R.S.
        • Vasudevan S.A.
        Surgical management of hepatoblastoma and recent advances.
        Cancers (Basel). 2019; 11https://doi.org/10.3390/CANCERS11121944
        • Trobaugh-Lotrario A.D.
        • López-Terrada D.
        • Li P.
        • et al.
        Hepatoblastoma in patients with molecularly proven familial adenomatous polyposis: Clinical characteristics and rationale for surveillance screening.
        Pediatr Blood Cancer. 2018; 65: e27103
        • Triana Junco P.
        • Cano E.M.
        • Dore M.
        • et al.
        Prognostic Factors for Liver Transplantation in Unresectable Hepatoblastoma.
        Eur J Pediatr Surg. 2019; 29: 28-32
        • Cruz R.J.
        • Ranganathan S.
        • Mazariegos G.
        • et al.
        Analysis of national and single-center incidence and survival after liver transplantation for hepatoblastoma: new trends and future opportunities.
        Surgery. 2013; 153: 150-159
        • Lakshminarayanan B.
        • Hughes-Thomas A.O.
        • Grant H.W.
        Epidemiology of adhesions in infants and children following open surgery.
        Semin Pediatr Surg. 2014; 23: 344-348
        • Fredriksson F.
        • Christofferson R.H.
        • Lilja H.E.
        Adhesive small bowel obstruction after laparotomy during infancy.
        Br J Surg. 2016; 103: 284-289
        • Winterberg P.D.
        • Garro R.
        Long-term outcomes of kidney transplantation in children.
        Pediatr Clin North America. 2019; 66: 269-280
        • Perez-Aytes A.
        • Marin-Reina P.
        • Boso V.
        • et al.
        Mycophenolate mofetil embryopathy: A newly recognized teratogenic syndrome.
        Eur J Med Genet. 2017; 60: 16-21
        • McDonald S.P.
        • Craig J.C.
        Long-term survival of children with end-stage renal disease.
        New Engl J Med. 2004; 350: 2654-2662
        • Vimalesvaran S.
        • Souza L.N.
        • Deheragoda M.
        • et al.
        Outcomes of adults who received liver transplant as young children.
        EClinicalMedicine. 2021; 38: 100987
        • Miloh T.
        • Barton A.
        • Wheeler J.
        • et al.
        Immunosuppression in pediatric liver transplant recipients: Unique aspects.
        Liver Transplant. 2017; 23: 244-256
        • Feng S.
        • Bucuvalas J.C.
        • Mazariegos G.v.
        • et al.
        Efficacy and safety of immunosuppression withdrawal in pediatric liver transplant recipients: moving toward personalized management.
        Hepatology. 2021; 73: 1985-2004
        • Lipshultz S.E.
        • Adams M.J.
        • Colan S.D.
        • et al.
        Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association.
        Circulation. 2013; 128: 1927-1955
        • Longhi A.
        • Ferrari S.
        • Bacci G.
        • et al.
        Long-term follow-up of patients with doxorubicin-induced cardiac toxicity after chemotherapy for osteosarcoma.
        Anti-Cancer Drugs. 2007; 18: 737-744
        • Armenian S.H.
        • Hudson M.M.
        • Mulder R.L.
        • et al.
        Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: A report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
        The Lancet Oncol. 2015; 16: e123-e136
        • Mancilla T.R.
        • Iskra B.
        • Aune G.J.
        Doxorubicin-induced cardiomyopathy in children.
        Compr Physiol. 2019; 9: 905-931
        • Harake D.
        • Franco V.I.
        • Henkel J.M.
        • et al.
        Cardiotoxicity in childhood cancer survivors: Strategies for prevention and management.
        Future Cardiol. 2012; 8: 647-670
        • Langholz B.
        • Skolnik J.M.
        • Barrett J.S.
        • et al.
        Dactinomycin and vincristine toxicity in the treatment of childhood cancer: a retrospective study from the Children’s Oncology Group.
        Pediatr Blood Cancer. 2011; 57: 252-257
        • DM G
        • P N
        • NE B
        • et al.
        Severe hepatic toxicity after treatment with vincristine and dactinomycin using single-dose or divided-dose schedules: a report from the National Wilms’ Tumor Study.
        J Clin Oncol. 1990; 8: 1525-1530
        • Oeffinger K.C.
        • Hudson M.M.
        Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors.
        CA: A Cancer J Clinicians. 2004; 54: 208-236
        • van den Berg M.H.
        • Overbeek A.
        • Lambalk C.B.
        • et al.
        Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve.
        Hum Reprod. 2018; 33: 1474-1488
        • Salama M.
        • Woodruff T.K.
        Anticancer treatments and female fertility: clinical concerns and role of oncologists in oncofertility practice.
        Expert Rev Anticancer Ther. 2017; 17: 687-692
        • Al-Mahayri Z.N.
        • AlAhmad M.M.
        • Ali B.R.
        Long-term effects of pediatric acute lymphoblastic leukemia chemotherapy: can recent findings inform old strategies?.
        Front Oncol. 2021; 11https://doi.org/10.3389/FONC.2021.710163/TEXT
        • Mora E.
        • Lavoie Smith E.M.
        • Donohoe C.
        • et al.
        Vincristine-induced peripheral neuropathy in pediatric cancer patients.
        Am J Cancer Res. 2016; 6 (Available at:): 2416-2430
        • Ness K.K.
        • Jones K.E.
        • Smith W.A.
        • et al.
        Chemotherapy-related neuropathic symptoms and functional impairment in adult survivors of extracranial solid tumors of childhood: results from the St. Jude Lifetime Cohort Study.
        Arch Phys Med Rehabil. 2013; 94: 1451-1457
        • Smith E.M.L.
        • Li L.
        • Hutchinson R.J.
        • et al.
        Measuring vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia.
        Cancer Nurs. 2013; 36https://doi.org/10.1097/NCC.0B013E318299AD23
        • Kandula T.
        • Farrar M.A.
        • Cohn R.J.
        • et al.
        Chemotherapy-induced peripheral neuropathy in long-term survivors of childhood cancer clinical, neurophysiological, functional, and patient-reported outcomes.
        JAMA Neurol. 2018; 75: 980-988
        • Shim H.J.
        • Kim H.J.
        • Hwang J.E.
        • et al.
        Long term complications and prognostic factors in locally advanced nasopharyngeal carcinoma treated with docetaxel, cisplatin, 5-fluorouracil induction chemotherapy followed by concurrent chemoradiotherapy: A retrospective cohort study.
        Medicine. 2020; 99: e23173
        • Skinner R.
        Late renal toxicity of treatment for childhood malignancy: risk factors, long-term outcomes, and surveillance.
        Pediatr Nephrol. 2018; 33: 215-225
        • Altena R.
        • de Haas E.C.
        • Nuver J.
        • et al.
        Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer.
        Br J Cancer. 2009; 100: 1861-1866
        • Chovanec M.
        • Abu Zaid M.
        • Hanna N.
        • et al.
        Long-term toxicity of cisplatin in germ-cell tumor survivors.
        Ann Oncol. 2017; 28: 2670-2679
        • Bjerring A.W.
        • Fosså S.D.
        • Haugnes H.S.
        • et al.
        The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: a 30-year follow-up.
        Eur Heart J - Cardiovasc Imaging. 2021; 22: 443-450
        • Kobayashi K.
        • Ratain M.J.
        Pharmacodynamics and long-term toxicity of etoposide.
        Cancer Chemother Pharmacol. 1994; 34https://doi.org/10.1007/BF00684866
        • Weaver L.
        • Samkari A.
        Neurological Complications of Childhood Cancer.
        Semin Pediatr Neurol. 2017; 24: 60-69
        • Gibson T.M.
        • Mostoufi-Moab S.
        • Stratton K.L.
        • et al.
        Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970–99: a report from the Childhood Cancer Survivor Study cohort.
        Lancet Oncol. 2018; 19: 1590-1601
        • Lee M.
        • Wang Q.
        • Wanchoo R.
        • et al.
        Chronic Kidney Disease in Cancer Survivors.
        Adv Chronic Kidney Dis. 2021; 28: 469-476.e1
        • Hudson M.M.
        Reproductive outcomes for survivors of childhood cancer.
        Obstet Gynecol. 2010; 116: 1171-1183
        • Ishida Y.
        • Maeda M.
        • Adachi S.
        • et al.
        Secondary cancer after a childhood cancer diagnosis: viewpoints considering primary cancer.
        Int J Clin Oncol. 2018; 23: 1178-1188
        • Wasilewski-Masker K.
        • Kaste S.C.
        • Hudson M.M.
        • et al.
        Bone mineral density deficits in survivors of childhood cancer: Long-term foIIow-up guidelines and review of the literature.
        Pediatrics. 2008; 121https://doi.org/10.1542/PEDS.2007-1396
        • Inskip P.D.
        • Veiga L.H.S.
        • Brenner A.v.
        • et al.
        Hypothyroidism following radiation therapy for childhood cancer: a report from the childhood cancer survivor study.
        Radiat Res. 2018; 190: 117
        • Sklar C.A.
        • Antal Z.
        • Chemaitilly W.
        • et al.
        Hypothalamic-pituitary and growth disorders in survivors of childhood cancer: An Endocrine Society Clinical Practice Guideline.
        J Clin Endocrinol Metab. 2018; 103: 2761-2784
        • Lerner S.E.
        • Huang G.J.M.
        • McMahon D.
        • et al.
        Growth hormone therapy in children after cranial/craniospinal radiation therapy: sexually dimorphic outcomes.
        J Clin Endocrinol Metab. 2004; 89: 6100-6104
        • Hanif I.
        • Mahmoud H.
        • Pui C.-H.
        Avascular femoral head necrosis in pediatric cancer patients.
        Med Pediatr Oncol. 1993; 21: 655-660
        • Madadi F.
        • Shamsian B.S.
        • Alavi S.
        • et al.
        Avascular necrosis of the femoral head in children with acute lymphoblastic leukemia: A 4- to 9-year follow-up study.
        Orthopedics. 2011; 34https://doi.org/10.3928/01477447-20110826-07
        • Wong K.L.
        • Song T.T.
        • Wee J.
        • et al.
        Sensorineural hearing loss after radiotherapy and chemoradiotherapy: A single, blinded, randomized study.
        J Clin Oncol. 2006; 24: 1904-1909
        • Jussila M.P.
        • Remes T.
        • Anttonen J.
        • et al.
        Late vertebral side effects in long-term survivors of irradiated childhood brain tumor.
        PLoS ONE. 2018; 13https://doi.org/10.1371/JOURNAL.PONE.0209193
        • Arnold N.
        • Merzenich H.
        • Wingerter A.
        • et al.
        Promotion of arterial stiffness by childhood cancer and its characteristics in adult long-term survivors.
        J Am Heart Assoc. 2021; 10: 1-21
        • Wright K.D.
        • Green D.M.
        • Daw N.C.
        Late effects of treatment for wilms tumor.
        Pediatric hematology oncology journal. 2009; 26: 407-413
        • Wong K.F.
        • Reulen R.C.
        • Winter D.L.
        • et al.
        Risk of adverse health and social outcomes up to 50 years after wilms tumor: The British childhood cancer survivor study.
        J Clin Oncol. 2016; 34: 1772-1779
        • Friedman D.L.
        • Whitton J.
        • Leisenring W.
        • et al.
        Subsequent neoplasms in 5-year survivors of childhood cancer: the childhood cancer survivor study.
        JNCI J Natl Cancer Inst. 2010; 102: 1083
        • Reulen R.C.
        • Frobisher C.
        • Winter D.L.
        • et al.
        Long-term risks of subsequent primary neoplasms among survivors of childhood cancer.
        JAMA - J Am Med Assoc. 2011; 305: 2311-2319
        • Daniel C.L.
        • Kohler C.L.
        • Stratton K.L.
        • et al.
        Predictors of colorectal cancer surveillance among survivors of childhood cancer treated with radiation: A report from the Childhood Cancer Survivor Study.
        Cancer. 2015; 121: 1856-1863
        • Brinkman T.M.
        • Recklitis C.J.
        • Michel G.
        • et al.
        Psychological symptoms, social outcomes, socioeconomic attainment, and health behaviors among survivors of childhood cancer: Current state of the literature.
        J Clin Oncol. 2018; 36: 2190-2197
        • Gunnes M.W.
        • Lie R.T.
        • Bjørge T.
        • et al.
        Economic independence in survivors of cancer diagnosed at a young age: A Norwegian national cohort study.
        Cancer. 2016; 122: 3873-3882
        • Crochet E.
        • Tyc V.L.
        • Wang M.
        • et al.
        Posttraumatic stress as a contributor to behavioral health outcomes and health care utilization in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
        J Cancer Survivorship. 2019; 13: 981-992
        • Karlson C.W.
        • Alberts N.M.
        • Liu W.
        • et al.
        Longitudinal pain and pain interference in long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.
        Cancer. 2020; 126: 2915-2923
        • Kaye A.D.
        • Jones M.R.
        • Kaye A.M.
        • et al.
        Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse (Part 2).
        Pain Physician. 2017; 20: S111-S133
        • Smitherman A.B.
        • Mohabir D.
        • Wilkins T.M.
        • et al.
        Early Post-Therapy Prescription Drug Usage among Childhood and Adolescent Cancer Survivors.
        J Pediatr. 2018; 195: 161-168.e7
        • Charipova K.
        • Gress K.L.
        • Urits I.
        • et al.
        Management of patients with chronic pain in ambulatory surgery Centers.
        Cureus. 2020; 12https://doi.org/10.7759/CUREUS.10408
        • Zichová A.
        • Eckschlager T.
        • Ganevová M.
        • et al.
        Subsequent neoplasms in childhood cancer survivors.
        Cancer Epidemiol. 2020; 68https://doi.org/10.1016/j.canep.2020.101779
      1. Children’s Oncology Group.
        (Available at:) (Accessed May 10, 2022)
        • Erdmann F.
        • Frederiksen L.E.
        • Bonaventure A.
        • et al.
        Childhood cancer: Survival, treatment modalities, late effects and improvements over time.
        Cancer Epidemiol. 2021; 71https://doi.org/10.1016/j.canep.2020.101733
        • Taylor A.J.
        • Winter D.L.
        • Pritchard-Jones K.
        • et al.
        Second primary neoplasms in survivors of Wilms’ tumour - A population-based cohort study from the British Childhood Cancer Survivor Study.
        Int J Cancer. 2008; 122: 2085-2093